Kainos Medicine Statistics

Total Valuation

Kainos Medicine has a market cap or net worth of KRW 35.97 billion. The enterprise value is 36.31 billion.

Market Cap	35.97B
Enterprise Value	36.31B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Kainos Medicine has 33.09 million shares outstanding.

Current Share Class	33.09M
Shares Outstanding	33.09M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	22.49%
Owned by Institutions (%)	n/a
Float	23.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	43.83
PB Ratio	3.05
P/TBV Ratio	7.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.07
EV / Sales	44.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.48

Financial Position

The company has a current ratio of 5.31, with a Debt / Equity ratio of 0.03.

Current Ratio	5.31
Quick Ratio	4.69
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	-261.64

Financial Efficiency

Return on equity (ROE) is -82.19% and return on invested capital (ROIC) is -49.21%.

Return on Equity (ROE)	-82.19%
Return on Assets (ROA)	-44.66%
Return on Invested Capital (ROIC)	-49.21%
Return on Capital Employed (ROCE)	-97.45%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

In the past 12 months, Kainos Medicine has paid 1.09 million in taxes.

Income Tax	1.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.41% in the last 52 weeks. The beta is 1.29, so Kainos Medicine's price volatility has been higher than the market average.

Beta (5Y)	1.29
52-Week Price Change	-71.41%
50-Day Moving Average	1,104.96
200-Day Moving Average	1,939.78
Relative Strength Index (RSI)	50.94
Average Volume (20 Days)	481,104

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kainos Medicine had revenue of KRW 820.50 million and -11.83 billion in losses. Loss per share was -421.05.

Revenue	820.50M
Gross Profit	570.51M
Operating Income	-11.58B
Pretax Income	-11.83B
Net Income	-11.83B
EBITDA	-10.49B
EBIT	-11.58B
Loss Per Share	-421.05

Full Income Statement

Balance Sheet

The company has 6.43 billion in cash and 378.32 million in debt, giving a net cash position of 6.05 billion or 182.93 per share.

Cash & Cash Equivalents	6.43B
Total Debt	378.32M
Net Cash	6.05B
Net Cash Per Share	182.93
Equity (Book Value)	11.79B
Book Value Per Share	164.98
Working Capital	6.35B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.43 billion and capital expenditures -80,000, giving a free cash flow of -10.43 billion.

Operating Cash Flow	-10.43B
Capital Expenditures	-80,000
Free Cash Flow	-10.43B
FCF Per Share	-315.21

Full Cash Flow Statement

Margins

Gross Margin	69.53%
Operating Margin	-1,411.78%
Pretax Margin	-1,441.37%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Kainos Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,474.97%
Shareholder Yield	n/a
Earnings Yield	-32.89%
FCF Yield	-29.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 24, 2022. It was a reverse split with a ratio of 0.2.

Last Split Date	Jun 24, 2022
Split Type	Reverse
Split Ratio	0.2

Scores

Kainos Medicine has an Altman Z-Score of 21.09 and a Piotroski F-Score of 1.

Altman Z-Score	21.09
Piotroski F-Score	1